
Identification of disease-causing mutations by functional complementation of patient-derived fibroblast cell lines.
Methods Mol. Biol. 1567, 391-406 (2017)
Diagnosis of mitochondrial disorders is still hampered by their phenotypic and genotypic heterogeneity. In many cases, exome sequencing, the state-of-the-art method for genetically diagnosing mitochondrial disease patients, does not allow direct identification of the disease-associated gene but rather results in a list of variants in candidate genes. Here, we present a method to validate the disease-causing variant based on functional complementation assays. First, cell lines expressing a wild-type cDNA of the candidate genes are generated by lentiviral infection of patient-derived fibroblasts. Next, oxidative phosphorylation is measured by the Seahorse XF analyzer to assess rescue efficiency.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Disease-associated Gene ; Exome Sequencing ; Functional Complementation ; Mitochondrial Disorders ; Oxygen Consumption Rate
ISSN (print) / ISBN
1064-3745
e-ISSN
1940-6029
Konferenztitel
Mitochondria
Zeitschrift
Methods in Molecular Biology
Quellenangaben
Band: 1567,
Seiten: 391-406
Verlag
Springer
Verlagsort
Berlin [u.a.]
Begutachtungsstatus
peer-reviewed
Institut(e)
Institute of Human Genetics (IHG)